A detailed history of Gts Securities LLC transactions in Liquidia Corp stock. As of the latest transaction made, Gts Securities LLC holds 16,000 shares of LQDA stock, worth $170,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Previous 10,100 58.42%
Holding current value
$170,400
Previous $121,000 32.23%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.9 - $14.11 $10,421 - $16,522
1,171 Added 3.1%
38,940 $389,000
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $776,000 - $1.02 Million
-64,883 Reduced 63.21%
37,769 $453,000
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $682,884 - $1.01 Million
60,166 Added 141.61%
102,652 $1.51 Million
Q4 2023

Feb 14, 2024

BUY
$5.77 - $12.19 $245,144 - $517,904
42,486 New
42,486 $511,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $685M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.